The Drug Regulatory Authority of Pakistan (DRAP) on Monday approved Chinese Sinopharm corona vaccine for emergency use. 

DRAP on Monday approved Chinese state-owned firm Sinopharm's corona vaccine for emergency use, the second vaccine to be given approval for use in the country. Earlier, on Friday Drap had authorised the Oxford University-AstraZeneca COVID-19 vaccine for emergency use in Pakistan.

A spokesperson for the regulatory body said, "In a meeting conducted by [the] Registration Board of Drap today January 18, 2021, another vaccine manufactured by China National Pharmaceutical Group (Sinopharm) has also been given EUA (emergency use authorisation). Both the Oxford and Sinopharm vaccines were evaluated for their safety and quality and granted EUA "with certain conditions."

Also Read:

Iran, six other nations lose right to vote in UNGA

Taiwan revokes major festival as domestic COVID-19 cases spurt

One rioter hoped to sell Nancy Pelosi's laptop to Russian spy agency: FBI